ORKA
Oruka Therapeutics, Inc.
84.40$
-0.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10,832.1% | -953.2% | -98.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 489.5% | 81.8% | 5.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1,824.0% | 1,383.1% | -103.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 471.6% | 62.8% | 0.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -215.6% | -1,596.3% | 45.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 14,892.3% | 3,130.0% | -7.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6,929.2% | 580.5% | -60.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11,303.7% | -1,016.0% | -98.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.